Impact of sarcopenia and inflammation on patients with advanced non-small cell lung cancer (ncscl) treated with immune checkpoint inhibitors (icis): a prospective study

HIGHLIGHTS

• who: Marta Tenuta et al. from the Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena , have published the Article: Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study, in the Journal: (JOURNAL) of 30/Nov/2021
• what: The aim of this prospective observational study was to investigate the relationship between ICI treatment response and immunological profile in patients with advanced non-small cell lung cancer (NSCLC). Kaplan-Meier survival analysis was conducted to assess the median time . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.